Celularity Valuation
| CELUW Stock | USD 0.02 0.0006 3.97% |
Celularity seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Celularity from analyzing the firm fundamentals such as Return On Equity of -1.54, profit margin of (2.64) %, and Number Of Shares Shorted of 175.73 K as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Celularity's price fluctuation is out of control at this time. Calculation of the real value of Celularity is based on 3 months time horizon. Increasing Celularity's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Celularity stock is determined by what a typical buyer is willing to pay for full or partial control of Celularity. Since Celularity is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Celularity Stock. However, Celularity's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0157 | Real 0.012 | Hype 0.0163 | Naive 0.007901 |
The intrinsic value of Celularity's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Celularity's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Celularity helps investors to forecast how Celularity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Celularity more accurately as focusing exclusively on Celularity's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Celularity's intrinsic value based on its ongoing forecasts of Celularity's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Celularity's closest peers.
Celularity Cash |
|
Celularity Valuation Trend
Analysing the historical paterns of Celularity's enterprise value and its market capitalization is a good way to estimate and gauge the value of Celularity over time and is usually enough for investors to make rational market timing decisions.
Celularity Total Value Analysis
Celularity is currently anticipated to have takeover price of 0 with market capitalization of 0, debt of 39.24 M, and cash on hands of 38 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Celularity fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 39.24 M | 38 M |
Celularity Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Celularity has an asset utilization ratio of 15.83 percent. This indicates that the Company is making $0.16 for each dollar of assets. An increasing asset utilization means that Celularity is more efficient with each dollar of assets it utilizes for everyday operations.Celularity Profitability Analysis
The company reported the revenue of 22.77 M. Net Loss for the year was (196.29 M) with profit before overhead, payroll, taxes, and interest of 0.About Celularity Valuation
Our relative valuation model uses a comparative analysis of Celularity. We calculate exposure to Celularity's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Celularity's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.8 M | 6.5 M | |
| Pretax Profit Margin | (8.62) | (9.05) | |
| Operating Profit Margin | (8.44) | (8.02) | |
| Net Loss | (8.62) | (9.05) | |
| Gross Profit Margin | 0.30 | 0.51 |
Celularity Growth Indicators
Investing in growth stocks can be very risky. If the company such as Celularity does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 19.4 M | |
| Quarterly Earnings Growth Y O Y | -0.613 |
Celularity Current Valuation Indicators
Valuation refers to the process of determining the present value of Celularity and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Celularity we look at many different elements of the entity such as Celularity's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Celularity, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Celularity's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Celularity's worth.Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.